Guidelines for Vaccinating Pregnant Women
|GUIDELINES FOR VACCINATING PREGNANT WOMEN|
Vaccination of pregnant women should be considered on the basis of risk vs. benefit. Risk to the fetus from vaccination of the mother during pregnancy is primarily theoretical. There is no evidence of risk from vaccinating pregnant women with inactivated virus or bacterial vaccines or toxoids. Generally, live vaccines are contraindicated for pregnant women because of the theoretical risk of transmission of the vaccine virus to the fetus. If a live vaccine is administered to a pregnant woman, or if she becomes pregnant within 4 weeks after vaccination, she should be counseled about the potential risks to the fetus. Passive immunization with immune globulin products has shown no risks to the fetus.The following table may be used as a general guide.
|VACCINE†||SHOULD BE CONSIDERED
IF OTHERWISE INDICATED
|Human Papillomavirus (HPV)2||•|
|Measles, Mumps, Rubella (MMR)*||•|
|Inactivated Poliovirus (IPV)6||•|
|Tetanus, Diphtheria (Td)||•|
|Tetanus, Diphtheria, Pertussis (Tdap)7||•|
|TRAVEL & OTHER||Anthrax8||•|
|Japanese Encephalitis (JE)9||•|
|Typhoid (Oral* & Parenteral)10||•|
|*Live attenuated vaccine|
For information on individual vaccines, see the product entries in this Section or contact the manufacturer or call the National Immunization Hotline at 800-232-4636.
Source: Advisory Committee in Immunization Practices. Guidelines for Vaccinating Pregnant Women. 1998 Oct [updated 2012 March].
Available at: http://www.cdc.gov/vaccines/pubs/preg-guide.htm.